Zometa and Halothane drug interactions - a phase IV clinical study of FDA data
Summary:
We study 71,746 people who take Zometa (zoledronic acid) and Halothane (halothane). There is no drug interaction reported.
The study analyzes what interactions people have when they take Zometa and Halothane. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Zometa?
Zometa has active ingredients of zoledronic acid. It is often used in multiple myeloma. eHealthMe is studying from 71,434 Zometa users. Check the latest studies of Zometa.
What is Halothane?
Halothane has active ingredients of halothane. eHealthMe is studying from 312 Halothane users. Check the latest studies of Halothane.
No report is found.
Do you take Zometa and Halothane?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on zoledronic acid and halothane (the active ingredients of Zometa and Halothane, respectively), and Zometa and Halothane (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Glimepiride and Abacavir - 7 seconds ago
- Could Cephalexin cause Discomfort? - 26 seconds ago
- Could Fluconazole cause Uterine Fibroids? - 33 seconds ago
- Could Valproic Acid cause Borderline Personality Disorder? - 34 seconds ago
- Pancreatic Neuroendocrine Tumor Metastatic and Malignant Neoplasm Progression - 34 seconds ago
- Lung Cancer Metastatic and Malignant Neoplasm Progression - 36 seconds ago
- Could Cozaar cause Malignant Neoplasm Progression? - 38 seconds ago
- Drug interactions of Butrans and Xeljanz - 42 seconds ago
- Could Aredia cause Vitamin B12 Deficiency? - 42 seconds ago
- Metastatic Carcinoid Tumor and Malignant Neoplasm Progression - 43 seconds ago